Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Current Deferred Revenue: 2013-2015

Historic Current Deferred Revenue for Armata Pharmaceuticals (ARMP) over the last 3 years, with Dec 2015 value amounting to $245,000.

  • Armata Pharmaceuticals' Current Deferred Revenue rose 11.11% to $20,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $20,000, marking a year-over-year increase of 11.11%. This contributed to the annual value of $245,000 for FY2015, which is 0.41% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Current Deferred Revenue of $245,000 as of FY2015, which was up 0.41% from $244,000 recorded in FY2014.
  • Over the past 5 years, Armata Pharmaceuticals' Current Deferred Revenue peaked at $245,000 during FY2015, and registered a low of $244,000 during FY2013.
  • Over the past 3 years, Armata Pharmaceuticals' median Current Deferred Revenue value was $244,000 (recorded in 2014), while the average stood at $244,333.
  • Data for Armata Pharmaceuticals' Current Deferred Revenue shows a peak YoY increased of 0.41% (in 2015) over the last 5 years.
  • Yearly analysis of 3 years shows Armata Pharmaceuticals' Current Deferred Revenue stood at $244,000 in 2013, then remained steady at $244,000 in 2014, then grew by 0.41% to $245,000 in 2015.